Further support for active surveillance in the management of low-volume, low-grade prostate cancer

European Urology

Volumn 58, Issue 6, 2010, Pages 836-837

  Albertsen, Peter ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; PROSTATE SPECIFIC ANTIGEN;

CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; DIGITAL RECTAL EXAMINATION; DISEASE SURVEILLANCE; EDITORIAL; FOLLOW UP; GLEASON SCORE; HUMAN; INCONTINENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; QUALITY OF LIFE; TUMOR VOLUME; UNITED KINGDOM; UNITED STATES;

ANDROGEN ANTAGONISTS; BIOPSY; DISEASE-FREE SURVIVAL; HUMANS; MALE; NEOPLASM STAGING; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WATCHFUL WAITING;

EID: 78049467028     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.09.003     Document Type: Editorial

References (10)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. S.M. Collin, R.M. Martin, and C. Metcalfe Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study Lancet Oncol 9 2008 445 452
3. I.M. Thompson, P.J. Goodman, and C.M. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 2003 215 224
4. G.L. Lu-Yao, P.C. Albertsen, and D.F. Moore Outcomes of localized prostate cancer following conservative management JAMA 302 2009 1202 1209
5. P.C. Albertsen, J.A. Hanley, and G.H. Barrows Prostate cancer and the Will Rogers phenomenon J Natl Cancer Inst 97 2005 1248 1253
6. F.H. Schroeder, J. Hugosson, M.J. Roobol ERSPC Investigators Screening and prostate cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
7. J.I. Epstein, P.C. Walsh, M. Carmichael, and C.B. Brendler Pathological and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368 374
8. M.A. Dall'Era, M.R. Cooperberg, and J.M. Chan Active surveillance for early-stage prostate cancer. Review of current literature Cancer 112 2008 1650 1659
9. M.S. Soloway, C.T. Soloway, A. Eldefrawy, K. Acosta, B. Kava, and M. Manoharan Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment Eur Urol 58 2010 831 835
10. J.A. Eastham, E. Riedel, P.T. Scardino Polyp Prevention Trial Study Group Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations JAMA 289 2003 2695 2700